Raymond James Trust’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-15,495
Closed -$321K 1339
2024
Q2
$321K Sell
15,495
-812
-5% -$16.1K 0.01% 948
2024
Q1
$307K Buy
16,307
+2,439
+18% +$41.9K 0.01% 966
2023
Q4
$200K Buy
13,868
+983
+8% +$13.4K 0.01% 1145
2023
Q3
$224K Sell
12,885
-22
-0.2% -$459 0.01% 1034
2023
Q2
$269K Buy
12,907
+630
+5% +$13.7K 0.01% 946
2023
Q1
$289K Sell
12,277
-150
-1% -$4.03K 0.01% 881
2022
Q4
$347K Sell
12,427
-559
-4% -$14.3K 0.01% 768
2022
Q3
$304K Sell
12,986
-3,730
-22% -$113K 0.01% 783
2022
Q2
$564K Sell
16,716
-967
-5% -$33.9K 0.02% 545
2022
Q1
$617K Sell
17,683
-780
-4% -$26.7K 0.02% 560
2021
Q4
$562K Sell
18,463
-1,675
-8% -$54.6K 0.02% 593
2021
Q3
$660K Sell
20,138
-6,040
-23% -$193K 0.02% 524
2021
Q2
$792K Buy
+26,178
New +$862K 0.03% 457

Other funds holding OGN

Raymond James Trust's OGN Position: Q3 2024 in Review

Raymond James Trust sold out of Organon & Co (OGN) in Q3 2024, closing a stake of 15,495 shares — an estimated $321K sold.

Raymond James Trust first reported a position in OGN in Q2 2021 and held it in 13 quarters. The position peaked at $792K in Q2 2021. 723 funds tracked by Wall St. Rank hold OGN as of Q3 2024.

  • Raymond James Trust reported no remaining Organon & Co position as of Q3 2024 after selling out during the quarter.
  • Raymond James Trust sold 15,495 Organon & Co shares in Q3 2024, an estimated $321K.
  • Raymond James Trust first reported a position in Organon & Co in Q2 2021 and held it in 13 quarters.
  • Raymond James Trust's Organon & Co position peaked at $792K in Q2 2021.
  • 723 funds tracked by Wall St. Rank held Organon & Co as of Q3 2024.

Based on Raymond James Trust's 13F filing for Q3 2024, filed 12 Nov 2024.